As the biopharmaceutical market grows, so will the cell culture products market. Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals.
This report is focused on cell culture used in the research and production of biopharmaceuticals, analyzing the world cell culture market and the major trends driving this market in three specific segments:
- Sera, and
In addition to a thorough discussion of the technologies and techniques currently employed and emerging in the cell culture area, the Kalorama’s exhaustive report provides specific information on:
- Market Size, growth, and forecasts of the segments through 2011
- Competitive Market Share by leading supplier as of 2005.
- Estimated Market Share by Media Type (this is not available in other reports)
- Key Market Drivers and Restraints for suppliers, including discussions of biopharmaceutical pipelines, seasonal vaccine production, biomedical R&D directions, and the future of transgenic plant and animal production.
- Review of the various expression systems (Bacteria, Yeast, Insect, and Mammal) and the biopharmaceutical product manufactured by these systems
- Discussion of the trends and preferences in media types vying for dominance in the market, including the following:
- ADCF – animal derived component free media
- CD – chemically defined media
- CSFM – complete serum free medium
- PF – protein free media
- SF – serum free media
- SFM – serum free medium
- Profiles of 28 leading suppliers and information about M&A activities since 2003.
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company and cell culture supply company representatives included marketing directors, division managers, and product representatives.